DISEASE-SPECIFIC CANCER CONTROL
CANCER CONTROL 2014 103
9. Sankaranarayanan R, Dinshaw K, Nene BM, Ramadas K, Esmy PO, Jayant K, et al.
Cervical and oral cancer screening in India. Journal of medical screening 2006;13 Suppl
10. International Agency for Research on Cancer.
11. Sankaranarayanan R, Swaminathan R. Cancer Survival in Africa Asia the Caribbean and
Central America: IARC Scientific Publication, 2011.
12. Siegel R, Naishadham D, Jemal A. Cancer Statistics 2013. CA: a cancer journal for
13. International Agency for Research on Cancer. http://survcan.iarc.fr./.
14. Australian Institute of Health and Welfare (AIHW) & National Breast and Ovarian
Cancer Centre (NBOCC). Breast Cancer in Australia: an overview, 2009. Cancer series
no. 50. Cat. no. CAN 46. Canberra: AIHW, 2009.
15. International Agency for Research on Cancer. http://globocan.iarc.fr/factsheet.asp,
16. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy
and hormonal therapy for early breast cancer on recurrence and 15-year survival: an
overview of the randomised trials. The Lancet 2005;365(9472):1687-717.
17. Hill DJ, Giles GG, Russell IS, Collins JP, Mapperson KJ. Management of primary,
operable breast cancer in Victoria. Medical Journal of Australia 1990;152(2):67-72.
18. Fisher B. From Halsted to prevention and beyond: advances in the management of
breast cancer during the twentieth century. Eur J Cancer 1999;35(14):1963-73.
19. Kirwan CC. Breast cancer screening: what does the future hold? BMJ 2013;346:f87.
20. Baum M. Harms from breast cancer screening outweigh benefits if death caused by
treatment is included. BMJ 2013;346:f385.
21. Welch HG, Frankel BA. Likelihood that a woman with screen-detected breast cancer
has had her "life saved" by that screening. Archives of internal medicine
22. Bleyer A, Welch HG. Effect of three decades of screening mammography on breastcancer incidence. The
New England journal of medicine 2012;367(21):1998-2005.
23. Burton RC, Bell RJ, Thiagarajah G, Stevenson C. Adjuvant therapy, not mammographic
screening, accounts for most of the observed breast cancer specific mortality
reductions in Australian women since the national screening program began in 1991.
Breast cancer research and treatment 2012;131(3):949-55.
24. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L. Effect of mammographic
screening from age 40 years on breast cancer mortality at 10 years' follow-up: a
randomised controlled trial. The Lancet 2006;368(9552):2053-60.
25. EUROSCREEN Working Group. Summary of the evidence of breast cancer service
screening outcomes in Europe and first estimate of the benefit and harm balance sheet.
Med Screening 2012;19 (suppl 1):5-13.
26. Egger M, Schneider M, Davey Smith G. Spurious precision? Meta-analysis of
observational studies. BMJ 1998;316(7125):140-4.
27. Jorgensen KJ, Gotzsche PC. Overdiagnosis in publicly organised mammography
screening programmes: systematic review of incidence trends. BMJ 2009;339:b2587.
28. Morrell S, Barratt A, Irwig L, Howard K, Biesheuvel C, Armstrong B. Estimates of
overdiagnosis of invasive breast cancer associated with screening mammography.
Cancer Causes Control 2010;21(2):275-82.
29. Welch HG, Black WC. Overdiagnosis in cancer. Journal of the National Cancer Institute
30. Zahl PH, Jorgensen KJ, Gotzsche PC. Overestimated lead times in cancer screening has
led to substantial underestimation of overdiagnosis. British journal of cancer
31. Welch HG. Overdiagnosis and mammography screening: the question is no longer
whether, but how often it occurs. BMJ 2009;339:b1425.
32. Vaidya JS, Wenz F, Bulsara M, et al, On Behalf Of The TARGIT Trialists' Group. Riskadapted targeted intraoperative
radiotherapy versus whole-breast radiotherapy for
breast cancer: 5-year results for local control and overall survival from the TARGIT-A
randomised trial. http://www.sciencedirect.com/science/
33. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer
incidence and mortality. Breast cancer research: BCR 2004;6(6):229-39.
34. Sankaranarayanan R, Swaminathan R. Cancer Survival in Africa Asia the Caribbean and
Central America. IARC Scientific Publication, No 162 2011.
35. Ng EH, Ng FC, Tan PH, Low SC, Chiang G, Tan KP, et al. Results of intermediate
measures from a population-based, randomized trial of mammographic screening
prevalence and detection of breast carcinoma among Asian women: the Singapore
Breast Screening Project. Cancer 1998;82(8):1521-8.
36. McPherson K. Screening for breast cancer--balancing the debate. BMJ
37. White V, Pruden M, Giles G, Collins J, Jamrozik K, Inglis G, et al. The management of
early breast carcinoma before and after the introduction of clinical practice guidelines.
39. Byrne MJ, Jamrozik K, Parsons RW, Fitzgerald CJ, Dewar JM, Harvey JM, et al. Breast
cancer in Western Australia in 1989. II. Diagnosis and primary management. ANZ
Journal of Surgery 1993;63:7-23.
40. Hill DJ, Jamrozik K, White VM, Collins JP, Boyages J, Shugg D, et al. Surgical
management of breast cancer in Australia in 1995. Kings Cross NSW: National Breast
Cancer Centre, 1999.
41. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening
programme on mortality from breast cancer in England and Wales, 1990-8: comparison
of observed with predicted mortality. BMJ 2000;321:665-69.
42. Kalager M, Zelen M, Langmark F, Adamai H. Effect of screening mammography on
breast cancer mortality in Norway. New England Journal of Medicine 2010;263:1203-10.
43. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring
European countries with different levels of screening but similar access to treatment:
trend analysis of WHO mortality database. BMJ 2011;343:d4411.
44. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, et al. Randomized trial of
breast self-examination in Shanghai: final results. Journal of the National Cancer Institute
45. Semiglazov VF, Manikhas AG, Moiseenko VM, Protsenko SA, Kharikova RS, Seleznev IK,
et al. [Results of a prospective randomized investigation [Russia (st.petersburg)/WHO]
to evaluate the significance of self-examination for the early detection of breast
cancer]. Voprosy onkologii 2003;49(4):434-41.
46. U.S. Preventive Services Task Force. Clinical Guidelines: Screening for Breast Cancer:
U.S. Preventive Services Task Force Recommendation Statement Annals of internal
47. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year
results of a randomized trial in women aged 50-59 years. Journal of the National Cancer
48. Mittra I, Mishra GA, Singh S, Aranke S, Notani P, Badwe R, et al. A cluster randomized,
controlled trial of breast and cervix cancer screening in Mumbai, India: methodology
and interim results after three rounds of screening. International journal of cancer.
Journal international du cancer 2010;126(4):976-84.
49. Devi BC, Tang TS, Corbex M. Reducing by half the percentage of late-stage presentation
for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in
Sarawak, Malaysia. Annals of oncology: official journal of the European Society for
Medical Oncology / ESMO 2007;18(7):1172-6.
50. Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, et al. Relevance of breast
cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen:
patient-level meta-analysis of randomised trials. Lancet 2011;378(9793):771-84.
51. Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, et al. Comparisons between
different polychemotherapy regimens for early breast cancer: meta-analyses of longterm outcome among 100,000 women in 123 randomised
52. Burton R, Bell R. The global challenge of reducing breast cancer mortality. The oncologist